期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
CCL7 and CCL21 overexpression in gastric cancer is associated with lymph node metastasis and poor prognosis 被引量:12
1
作者 Tsann-Long Hwang Li-Yu Lee +3 位作者 Chee-ChanWang Ying Liang Shu-Fang Huang Chi-Ming Wu 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第11期1249-1256,共8页
AIM: To investigate how a complex network of CC chemokine ligands (eeLs) and their receptors influence the progression of tumor and metastasis.METHODS: In the present study, we used immunohistochemistry to examine... AIM: To investigate how a complex network of CC chemokine ligands (eeLs) and their receptors influence the progression of tumor and metastasis.METHODS: In the present study, we used immunohistochemistry to examine the expression of CCL7, CCL8 and CCL21 in 194 gastric cancer samples and adjacent normal tissues. We analyzed their correlation with tumor metastasis, clinicopathologic parameters and clinical outcome.RESULTS: We found that the higher expression of CCL7 and CCL21 in cancer tissues than in normal tissues was significantly correlated with advanced depth of wall invasion, lymph node metastasis and higher tumornode metastasis stage. Moreover, Kaplan-Meier survival analysis revealed that CCL7 and CCL21 overexpression in cancer tissues was correlated with poor prognosis.CONCLUSION: These results suggest that overexpression of these two CC chemokine ligands is associ- ated with tumor metastasis and serves as a prognostic factor in patients with gastric cancer. 展开更多
关键词 CC chemokine chemokine ligand 7 Che-mokine ligand 21 Gastric cancer Lymph node metas-tasis Poor prognosis
下载PDF
CONSTRUCTION OF EUKARYOTIC EXPRESSION VECTOR FOR HUMAN CCL21 AND CHARACTERIZATION OF ITS CHEMOTACTIC ACTIVITY
2
作者 侯丽 刘奇 +6 位作者 焦玉莲 张捷 王来城 马春燕 崔彬 张雪 赵跃然 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2006年第4期246-250,共5页
Objective: To obtain recombinant human CCL21 with biological activity from eukary0tic expression system for further use in cancer gene therapy. Methods: A fragment of human CCL21 gene was obtained from pSK-hCCL21 pl... Objective: To obtain recombinant human CCL21 with biological activity from eukary0tic expression system for further use in cancer gene therapy. Methods: A fragment of human CCL21 gene was obtained from pSK-hCCL21 plasmid digested by Xho I and BamH I, inserted into the responding sites of eukaryotic expression vector pVAX1, and then transfected into COS-7 cells by electroporation method. The expression of hCCL21 protein was detected by western blotting analysis. The in vitro chemotaxis assay was used to test the chemotactic function of the expression product to lymphocytes. Results: Human CCL21 protein was expressed by transfected COS-7 cells with recombinant plasmid containing hCCL21 gene, and was verified by western blotting. The in vitro chemotaxis assay demonstrated that human CCL21 protein had a potent chemotactic function to lymphocytes. Conclusion: Human CCL21 was successfully and transiently expressed in eukaryotic cells, which lays some foundation for the study of CCL21 gene therapy in murine tumor models. 展开更多
关键词 CC chemokine ligand 21 Eukaryotic expression Chemotaxis assay Gene therapy
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部